Related Experiment Video
Updated: Jul 11, 2025

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
DNMTs-mediated SOCS3 methylation promotes the occurrence and development of AML
Xiaohui Zhang1, Kai Zhang2, Jing Zhang1
1Department of Hematology, Handan Central Hospital, Handan, Hebei, China.
Objectives:
As a tumor suppressor gene, SOCS3 inhibits the growth of tumor cells by regulating JAK/STAT signaling pathway through negative feedback. This study aimed to investigate the biological function and mechanism of SOCS3 methylation mediated by DNMTs in the development of AML.
Methods:
Bone marrow samples were collected from 70 AML patients and 20 healthy volunteers. The expression and methylation status of each gene were detected by RT-qPCR, western blot and MS-PCR, and the growth and apoptosis rate of leukemia cell lines were detected by CCK-8 and flow cytometry. The effects of changes in SOCS3 gene expression and methylation status of AML cell lines were observed by gene transfection and gene knockdown.
Results:
The methylation rate of SOCS3 in AML initial treatment group was significantly higher than that in the remission group and the normal control group (60% vs. 0%, 0%). The expression of SOCS3 in the SOCS3 methylation group was significantly lower than that in the non-methylated group and control group, while the expression of DNMT1, DNMT3a, p-JAK2, p-STAT3 and p-STAT5 were significantly higher than those in the non-methylated group and control group. Demethylation treatment, SOCS3 transfection and DNMT3a knockdown could up-regulate the expression of SOCS3, which decreased the proliferation and increased the apoptosis of leukemia cell lines.
Conclusion:
SOCS3 methylation mediated by DNMTs promotes the occurrence and development of AML and can be used as a potential biomarker for the diagnosis and efficacy evaluation of AML.
Insights
SOCS3 gene methylation, mediated by DNMTs, promotes acute myeloid leukemia (AML) development. Restoring SOCS3 expression inhibits leukemia cell growth and increases apoptosis, suggesting SOCS3 as a potential AML biomarker.
Area of Science:
- Molecular Biology
- Oncology
- Epigenetics
Background:
- SOCS3 acts as a tumor suppressor by regulating the JAK/STAT signaling pathway.
- Aberrant gene methylation is implicated in various cancers, including AML.
Purpose of the Study:
- To investigate the role of SOCS3 methylation by DNMTs in AML pathogenesis.
- To explore SOCS3 as a potential diagnostic and prognostic biomarker for AML.
Main Methods:
- Analysis of SOCS3 expression and methylation in AML patient samples and cell lines.
- Assessment of leukemia cell proliferation and apoptosis using CCK-8 and flow cytometry.
- Manipulation of SOCS3 expression and DNMT activity via gene transfection, knockdown, and demethylation treatments.
Main Results:
- Higher SOCS3 methylation rates and lower SOCS3 expression were observed in AML patients compared to healthy controls.
- Increased expression of DNMTs (DNMT1, DNMT3a) and activated JAK/STAT signaling components (p-JAK2, p-STAT3, p-STAT5) were associated with SOCS3 methylation.
- Restoring SOCS3 expression through demethylation, transfection, or DNMT3a knockdown reduced leukemia cell proliferation and enhanced apoptosis.
Conclusions:
- DNMT-mediated SOCS3 methylation promotes AML development.
- SOCS3 methylation status can serve as a potential biomarker for AML diagnosis and treatment efficacy evaluation.
More Related Videos
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Differentiation of Common Myeloid Progenitor Cells